{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:58:07Z","timestamp":1773820687142,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.antiviral.2011.11.018","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T04:20:40Z","timestamp":1323404440000},"page":"219-224","source":"Crossref","is-referenced-by-count":25,"title":["RETRACTED: Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice"],"prefix":"10.1016","volume":"93","author":[{"given":"Sergey A.","family":"Tarasov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir V.","family":"Zarubaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeniy A.","family":"Gorbunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana A.","family":"Sergeeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg I.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.11.018_b0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/ecam\/nep152","article-title":"Using complementary and alternative medicines to target the host response during severe influenza","volume":"7","author":"Alleva","year":"2010","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"25","key":"10.1016\/j.antiviral.2011.11.018_b0010","doi-asserted-by":"crossref","first-page":"24127","DOI":"10.1074\/jbc.M413726200","article-title":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells","volume":"280","author":"Bernasconi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.11.018_b0015","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.4049\/jimmunol.175.10.6878","article-title":"Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection","volume":"175","author":"Carey","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2011.11.018_b0020","first-page":"1046","article-title":"Activity \u2013 United States and worldwide","volume":"57","author":"Influenza","year":"2008","journal-title":"Morb. Mortal. Wkly. Rep."},{"issue":"10","key":"10.1016\/j.antiviral.2011.11.018_b0025","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1469-0691.2010.03212.x","article-title":"Oseltamivir-resistant 2009\u20132010 pandemic influenza A (H1N1) in an immunocompromised patient","volume":"16","author":"Chan","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"issue":"25","key":"10.1016\/j.antiviral.2011.11.018_b0030","first-page":"2605","article-title":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans","volume":"360","author":"Dawood","year":"2009","journal-title":"Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team"},{"key":"10.1016\/j.antiviral.2011.11.018_b0035","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)65068-7","article-title":"Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus","volume":"156","author":"Dawson","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2011.11.018_b0040","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2011.11.018_b0045","unstructured":"Disease Outbreak News [abbreviated and edited]. World Health Organisation (Updated 21 May 2010). Available from <http:\/\/www.who.int\/csr\/don\/2010_05_21\/en\/index.html>."},{"key":"10.1016\/j.antiviral.2011.11.018_b0050","series-title":"Inflamation immunopharmacology: new tools for old diseases antiviral activity of anaferon for children in pandemic A\/H1N1 in mice 16th IUPHAR World Congress of Basis and Clinical Pharmacology. 17\u201323 July 2010","author":"Epstein","year":"2010"},{"key":"10.1016\/j.antiviral.2011.11.018_b0055","unstructured":"Epstein, O.I., Pharmacology of ultralow doses of antibodies to endogenous regulators of functions. Moscow: RAMS Publishing House, 2005, p. 226."},{"key":"10.1016\/j.antiviral.2011.11.018_b0060","unstructured":"Epstein, O.I., Ultralow doses (history of one research). Moscow, RAMS Publishing House, 2008, p. 336."},{"key":"10.1016\/j.antiviral.2011.11.018_b0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3201\/eid1604.091061","article-title":"Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice","volume":"16","author":"Garigliany","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.11.018_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007\u201308","volume":"15","author":"Hauge","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.11.018_b0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1086\/591851","article-title":"Developing new antiviral agents for influenza treatment: what does the future hold?","volume":"1","author":"Hayden","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.11.018_b0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0166-3542(95)00914-0","article-title":"Combination antiviral therapy for respiratory virus infections","volume":"29","author":"Hayden","year":"1996","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.11.018_b0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10517-009-0703-z","article-title":"Anaferon (pediatric formulation) in prophylactics of acute respiratory viral infection in children","volume":"148","author":"Kudin","year":"2009","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2011.11.018_b0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.antiviral.2009.11.001","article-title":"Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice","volume":"85","author":"Kurokawa","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.11.018_b0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/QCO.0b013e328336eaae","article-title":"Epidemic viral pneumonia","volume":"23","author":"Lapinsky","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2011.11.018_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkp161","article-title":"Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy","volume":"64","author":"Ludwig","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2011.11.018_b0105","first-page":"125","article-title":"A novel antiviral based on oral antibodies: clinical benefits in paediatric upper respiratory infections","volume":"10","author":"Martyushev-Poklad","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2011.11.018_b0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.med.59.061506.213121","article-title":"Medical management of influenza infection","volume":"59","author":"Moscona","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.antiviral.2011.11.018_b0115","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance\u2014disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2011.11.018_b0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.micinf.2008.09.013","article-title":"Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis","volume":"11","author":"Narasaraju","year":"2009","journal-title":"Microbes Infect."},{"issue":"Pt 8","key":"10.1016\/j.antiviral.2011.11.018_b0125","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/vir.0.79958-0","article-title":"Active NF-kappaB signalling is a prerequisite for influenza virus infection","volume":"85","author":"Nimmerjahn","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.11.018_b0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10517-009-0702-0","article-title":"Interferon status in children with acute respiratory infections. Interferon therapy","volume":"148","author":"Obraztsova","year":"2009","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2011.11.018_b0135","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2011.11.018_b0140","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/cc8044","article-title":"Intensive care adult patients with severe respiratory failure caused by Influenza (H1N1)v in Spain","volume":"13","author":"Rello","year":"2009","journal-title":"Crit. Care"},{"key":"10.1016\/j.antiviral.2011.11.018_b0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00441-010-1043-z","article-title":"Respiratory epithelial cells in innate immunity to influenza virus infection","volume":"343","author":"Sanders","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.antiviral.2011.11.018_b0150","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.79.10.6441-6448.2005","article-title":"Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection","volume":"79","author":"Schmitz","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.11.018_b0155","first-page":"7","article-title":"Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: experimental study of influenza infection in mice","volume":"49","author":"Sergeev","year":"2004","journal-title":"Antibiot. Khimioter."},{"key":"10.1016\/j.antiviral.2011.11.018_b0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1024782814058","article-title":"Immunotropic effects of potentiated antibodies to human interferon-\u03b3","volume":"1","author":"Sherstoboev","year":"2003","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2011.11.018_b0165","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10517-009-0378-5","article-title":"Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection","volume":"146","author":"Shishkina","year":"2008","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2011.11.018_b0170","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10517-010-1006-0","article-title":"Antiviral Activity of Anaferon (Pediatric Formulation) in Mice Infected with Pandemic Influenza Virus A(H1N1\/09)","volume":"149","author":"Shishkina","year":"2010","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2011.11.018_b0175","unstructured":"Tarasov, S., Dugina, J., Anaferon in pediatric febrile viral infections: a brief review of the results of clinical trials in Russia, 25th International Congress of Pediatrics \u00abfor the health and well-being of our children\u00bb, 25\u201330 August 2007, Athens, Greece (Abstract 0531)."},{"key":"10.1016\/j.antiviral.2011.11.018_b0185","unstructured":"Tarasov, S., Dugina, J., Oral antibody to interferon gamma in ultra low doses: clinical efficacy and interferon stimulation in patients with upper respiratory viral infections, 5th Congress of European Pharmacology Society, 13\u201317 July 2008, Manchester, UK (Abstract C026)."},{"key":"10.1016\/j.antiviral.2011.11.018_b0190","unstructured":"Tarasov, S., Zarubaev, V., Tafani, J., Dugina, J., Sergeeva, S., Epstein, O., Antibodies to interferon-gamma in ultra-low doses: a new option for pandemic influenza, 20th European Congress of Microbiology and infections Diseases, 10\u201313 April 2010, Vienna, Austria (Abstract P1106)."},{"key":"10.1016\/j.antiviral.2011.11.018_b0195","unstructured":"Tarasov, S.A., Mashkina, M.V., Development ELISA for quantitative measurement natural autoantibodies \u2013 potent endogeneous target of ultralow doses of antibodies, 2nd Moscow International Conference \u201cImmunophysiology: natural autoimmunity in physiology and pathology\u201d, 26\u201328 September 2008, Moscow, Russia (Abstract P203)."},{"key":"10.1016\/j.antiviral.2011.11.018_b0200","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/650581","article-title":"Delayed clearance of viral load, marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection","volume":"50","author":"To","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.11.018_b0205","first-page":"32","article-title":"Use of ultralow doses of antibodies to gamma-interferon in the treatment and prophylaxis of viral infections","volume":"53","author":"Vasil\u2019ev","year":"2008","journal-title":"Antibiot Khimioter"},{"issue":"17","key":"10.1016\/j.antiviral.2011.11.018_b0210","doi-asserted-by":"crossref","first-page":"11678","DOI":"10.1074\/jbc.M513286200","article-title":"NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity","volume":"281","author":"Wei","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.11.018_b0215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/649785","article-title":"Cytokine profiles induced by the novel swine-origin influenza A\/H1N1 virus: implications for treatment strategies","volume":"201","author":"Woo","year":"2010","journal-title":"J. Infect. Dis."}],"updated-by":[{"DOI":"10.1016\/j.antiviral.2019.02.011","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"record-id":"20147"},{"DOI":"10.1016\/j.antiviral.2019.02.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000}}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211005195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211005195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T16:51:01Z","timestamp":1556729461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211005195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0166354211005195"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.11.018","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.antiviral.2019.02.011","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}